Metraipolis › archive › dc_e14672170ccc

Orismilast, a Potent and Selective PDE4B/D Inhibitor, Reduces Protein Levels of Key Disease Driving Cytokines in the Skin of Patients With Plaque Psoriasis — Europe PMC PMID:40970551

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40970551
DOI
10.1111/exd.70153
License (as archived)
solo-consultazione
Archived
2026-11-10T04:29:15.507Z
SHA-256 of the archived text
b58134fd8ac808ca6e1bd505ed480076c0e03091ad37ec85837dc31547d05f10
Stable URL of this page
https://metraipolis.com/documento/dc_e14672170ccc

How to cite

Orismilast, a Potent and Selective PDE4B/D Inhibitor, Reduces Protein Levels of Key Disease Driving Cytokines in the Skin of Patients With Plaque Psoriasis — Europe PMC PMID:40970551 — Europe PMC (en), https://europepmc.org/article/MED/40970551 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e14672170ccc (Metraipolis archive dc_e14672170ccc, sha256 b58134fd8ac808ca6e1bd505ed480076c0e03091ad37ec85837dc31547d05f10)
BibTeX
@misc{dce14672170ccc,
  title = {Orismilast, a Potent and Selective PDE4B/D Inhibitor, Reduces Protein Levels of Key Disease Driving Cytokines in the Skin of Patients With Plaque Psoriasis — Europe PMC PMID:40970551},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40970551},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e14672170ccc; sha256 b58134fd8ac808ca6e1bd505ed480076c0e03091ad37ec85837dc31547d05f10},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40970551. Agents can read the archived copy with the MCP tool read_document.